C2 Dihydroceramide

• Description :

  C2 Dihydroceramide is a derivative of C2 Ceramide (HY-101180) . C2 Dihydroceramide enhances the ABCA1-mediated cholesterol efflux to apolipoprotein A-I (apoA-I) without causing cytotoxicity[1].

• UNSPSC :

  12352211

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Endogenous Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/c2-dihydroceramide.html

• Purity :

  98.0

• Smiles :

  CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O

• Molecular Formula :

  C20H41NO3

• Molecular Weight :

  343.54

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Ghering AB, et al., Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I. J Lipid Res. 2006 Dec;47 (12) :2781-8.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [13031-64-6]